Real-Options Valuation for a Biotechnology Company.
- Published in:
- Financial Analysts Journal, 2000, v. 56, n. 3, p. 76, doi. 10.2469/faj.v56.n3.2362
- By:
- Publication type:
- Article
Works matching DE "AGOURON Pharmaceuticals Inc."
Results: 7
1
2
Warner-Lambert acquires speculative Agouron pipeline.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 3, p. 211, doi. 10.1038/6913
- By:
- Publication type:
- Article
3
Collaboration on Immune Treatment.
- Published in:
- AIDS Patient Care & STDs, 1998, v. 12, n. 9, p. 723
- Publication type:
- Article
4
Espionage verdict prompts call for retraction of polymerase paper.
- Published in:
- Nature, 1998, v. 393, n. 6685, p. 504, doi. 10.1038/31064
- By:
- Publication type:
- Article
5
Company accused over lab data `theft.'
- Published in:
- Nature, 1997, v. 387, n. 6632, p. 444, doi. 10.1038/387444a0
- By:
- Publication type:
- Article
6
2000 Exhibitors Charlotte Convention Center.
- Published in:
- Oncology Nursing Forum, 2000, v. 27, n. 7, p. 1135
- Publication type:
- Article
7
US court slashes damages in polymerase-[beta] theft case.
- Published in:
- Nature, 2000, v. 407, n. 6806, p. 824, doi. 10.1038/35038228
- By:
- Publication type:
- Article